| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.3 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |